Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Eylea 40 mg/mL solution for injection in a vial
Lacuna Pharma Pty Ltd
Retinopathy of prematurity (ROP)
1 trial -
FAMPRIDINE, Placebo 515
Pari Pharma GmbH
Spinocerebellar ataxia
1 trial -
FAT EMULSIONS , Triheptanoin
Lacuna Pharma Pty Ltd
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
1 trial -
FE 999326
Ferring Pharmaceuticals
Bladder Cancer
1 trial -
FE 999913 vaginal tablet
Ferring Pharmaceuticals
Luteal Hormone Supplementation
1 trial -
FLECAINIDE
Pari Pharma GmbH
Patent Foramen Ovale Closure Atrial Arrhytmia or Tachycardia
1 trial -
FLUOROURACIL , OXALIPLATIN , GEMCITABINE , FOLIC ACID
Pari Pharma GmbH
Pancreatic adenocarcinoma (PAC)
1 trial -
FLUOROURACIL, DOCETAXEL, OPDIVO 10 mg/mL concentrate for solution for infusion., OXALIPLATIN, CALCIUM LEVOFOLINATE, CISPLATIN, DOXORUBICIN HYDROCHLORIDE
Verona Pharma Ireland Limited
Gastric adenocarcinoma with peritoneal metastases
1 trial -
FS MDPI
Teva Pharma GmbH
Asthma
2 trials -
Faceptor
Biotech Pharmaceutical Co.,
Breast Cancer Metastatic
2 trials -
Fentanyl Buccal Tablet
Teva Pharma GmbH
Chronic Pain
1 trial -
Fentanyl Buccal Tablets
Teva Pharma GmbH
Pain
1 trial -
Fentanyl Buccal Tablets Compared With Immediate-Release Oxycodone
Teva Pharma GmbH
Chronic Pain
1 trial -
Fezolinetant
Astellas Pharma Inc
Hot Flashes
1 trial -
Fianlimab, LIBTAYO 350 mg concentrate for solution for infusion., Placebo for Fianlimab
Lacuna Pharma Pty Ltd
Advanced Non-Small Cell Lung Cancer
1 trial -
Fingolimod
Novartis Pharmaceuticals
Multiple Sclerosis (MS)
1 trial -
Firibastat
Quantum Biopharma
Hypertension
1 trial -
Firibastat (QGC001) Period 1
Quantum Biopharma
Hypertension (HTN)
1 trial -
Firmonertinib
ArriVent BioPharma
NSCLC
1 trial -
Firmonertinib
ArriVent BioPharma
Non-Small-Cell Lung Cancer
1 trial -
Flecainide or Sotalol or Propafenone
Rhythm Pharmaceuticals Netherlands B.V.
Paroxysmal Atrial Fibrillation
1 trial -
Flucelvax Tetra - suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell cultures), PNEUMOVAX solution injectable en flacon Vaccin pneumococcique polyosidique, Pneumovax 23 oldatos injekció előretöltött fecskendőben Pneumococcus-poliszacharid vakcina, BOOSTRIX, suspension injectable en seringue préremplie Vaccin diphtérique, tétanique et coquelucheux (acellulaire multicomposé), (adsorbé, à teneur réduite en antigènes), Pneumovax 23 oldatos injekció e
Novartis Pharmaceuticals
Relapsing multiple sclerosis (RMS)
1 trial -
Fluticasone Propionate
Teva Pharma GmbH
Asthma
1 trial -
Fluticasone Propionate and Salmeterol Inhalation Powder
Teva Pharma GmbH
Asthma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources